Cargando…
Hyperprogression of a spindle‐cell squamous carcinoma of the esophagus after esophagectomy
Autores principales: | Ji, Yanli, Yang, Mei, Liu, Chengwu, Wang, Wenping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250840/ https://www.ncbi.nlm.nih.gov/pubmed/35668545 http://dx.doi.org/10.1111/1759-7714.14526 |
Ejemplares similares
-
TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?
por: VIEIRA, Felipe Monge, et al.
Publicado: (2021) -
Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication
por: Wang, Wei, et al.
Publicado: (2020) -
Spindle cell carcinoma of the esophagus: A multicenter analysis in comparison with typical squamous cell carcinoma
por: Zhang, Baihua, et al.
Publicado: (2016) -
A long-term survival case after surgical resection of skeletal muscle metastasis following esophagectomy for squamous cell carcinoma of the esophagus
por: Saito, Akira, et al.
Publicado: (2017) -
Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma
por: Sun, Dantong, et al.
Publicado: (2020)